FIG 7.

Antileishmania effect of DSHemsPC-AMB-Lip, AmBisome, and Fungizone in established CL lesions in susceptible BALB/c mice infected with L. major. AMB formulations were i.v. administered on days 23, 25, 27, 29, 31, 33, and 35 after parasite inoculation. Values represent means ± standard errors of the means (weeks 0 to 3, n = 10; weeks 4 to 6, n = 7; weeks 7 to 9, n = 4). The results for the DSHemsPC-AMB-Lip- and AmBisome-treated mice were significantly different from those for the control groups (mice receiving 5% dextrose and empty liposomes) (*, P < 0.05).